Viewing Study NCT02955251


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-03 @ 8:51 PM
Study NCT ID: NCT02955251
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2016-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module